Biomea Fusion, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
BMEA$0.60+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
Not applicable.
Exhibit Index
| Incorporated by Reference | ||||
|---|---|---|---|---|
| ExhibitNumber · Description · Form · Date · Number · Filed Herewith | ||||
| 3.1 | Amended and Restated Certificate of Incorporation, as currently in effect | 8-K | 4/20/2021 | 3.2 |
| 3.2 | Amended and Restated Bylaws, as currently in effect | 8-K | 4/20/2021 | 3.4 |
| 4.1 | Form of Common Stock Certificate | S-1/A | 4/12/2021 | 4.2 |
| 4.2 | Description of Registrant’s Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934 | 10-Q | 5/27/2021 | 4.4 |
| 4.3 | Investors’ Rights Agreement, dated December 18, 2020, by and among the Registrant and the investors listed therein | S-1 | 3/26/2021 | 10.1 |
| 10.1 | Secondary Sublease, dated August 18, 2020, by and between the Registrant and Interactive Memories, Inc. d/b/a Mixbook | S-1/A | 4/12/2021 | 10.2 |
| 10.2 | Form of Indemnification and Advancement Agreement for Directors and Officers | 10-Q | 5/16/2022 | 10.1 |
| 10.3 | Sublease Agreement between the Registrant and Box, Inc., dated September 7, 2022 | 8-K | 9/9/2022 | 10.1 |
| 10.4 | Equity Distribution Agreement, dated November 25, 2022, by and between the Company and Piper Sandler & Co. | 8-K | 11/25/2022 | 1.1 |
| 10.5(a)# | Form Executive Change in Control and Severance Agreement | S-1/A | 4/12/2021 | 10.11 |
| 10.5(b)# | Form of First Amendment to Change in Control and Severance Agreement | 8-K | 4/22/2022 | 99.1 |
| 10.5(c)# | Updated Form Executive Change in Control and Severance Agreement adopted November 13, 2023 | 10-K | 3/24/2024 | 10.5(C) |
| 10.6(a)# | 2020 Equity Incentive Plan | S-1 | 3/26/2021 | 10.3(a) |
| 10.6(b)# | Form of Stock Option Agreement under 2020 Equity Incentive Plan | S-1 | 3/26/2021 | 10.3(b) |
| 10.7(a)# | 2021 Incentive Award Plan | S-1/A | 4/12/2021 | 10.4(a) |
| 10.7(b)# | Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan | S-1/A | 4/12/2021 | 10.4(b) |
| 10.7(c)# | Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan | S-1/A | 4/12/2021 | 10.4(c) |
| 10.7(d)# | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan | S-1/A | 4/12/2021 | 10.4(d) |
| 10.8# | Employee Stock Purchase Plan | S-1/A | 4/12/2021 | 10.5 |
| 10.9# | Employment Offer Letter Agreement by and between the Registrant and Thomas Butler | S-1 | 3/26/2021 | 10.6 |
| 10.10# | Employment Offer Letter Agreement by and between the Registrant and Ramses Erdtmann | S-1 | 3/26/2021 | 10.7 |
| 10.11# | Employment Offer Letter Agreement by and between the Registrant and Franco Valle | 10-Q | 8/11/2021 | 10.2 |
| 10.12# | Employment Offer Letter Agreement by and between the Registrant and Juan Pablo Frias | 10-Q | 5/2/2024 | 10.1 |
| 10.13# | Non-Employee Director Compensation Program | S-1/A | 4/12/2021 | 10.9 |
| 10.14(a)# | 2023 Inducement Plan | S-8 | 1/5/2024 | 99.3(a) |
| 10.14(b)# | Form of Non-Qualified Stock Option Agreement under the 2023 Inducement Plan | S-8 | 1/5/2024 | 99.3(b) |
| 10.14(c)# | Form of Restricted Stock Award Agreement under the 2023 Inducement Plan | S-8 | 1/5/2024 | 99.3(c) | |
| 10.14(d)# | Form of Restricted Stock Unit Agreement under the 2023 Inducement Plan | S-8 | 1/5/2024 | 99.3(d) | |
| 19.1 | Insider Trading Policy | X | |||
| 21.1 | Subsidiaries of the Registrant | X | |||
| 23.1 | Consent of Independent Registered Public Accounting Firm | X | |||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 97.1 | Biomea Fusion, Inc.’s Compensation Recovery Policy | X | |||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.